Creative Biolabs

Lumipulse™ Human Amyloid Beta (1-40) Detection Kit

[CAT#: NK-2106-P006]

Neurodegenerative disease test kit; for total tau protein; cerebrospinal fluid; CE marked

Datasheet MSDS Request COA

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Product Overview


The in vitro diagnostic (IVD) immunoassay kit used in the LUMIULSE G system can quantitatively measure β-amyloid 1-40 in human cerebrospinal fluid (CSF).
The Lumipulse Gβ-amyloid protein 1-40 analysis method is designed to be used in conjunction with the Lumipulse Gβ-amyloid protein 1-42 analysis method to determine the ratio of amyloid in the clinical environment (β-amyloid protein 1-42 /β-amyloid protein Like protein 1-40). Diagnose dementia.
The CSF amyloid ratio (β-amyloid 1-42/β-amyloid 1-40 ratio) is intended to be used as a diagnostic aid for patients with cognitive impairment who are undergoing Alzheimer's disease (AD ) And other assessments of cognitive decline.
The CSF amyloid ratio is only used as an adjunct to other diagnostic evaluations, supporting the possibility of AD pathology.

Relevant Diseases

Alzheimer's Disease

Sample Type

cerebrospinal fluid


amyloid beta
Preparation and Storage

Research Use Only

This product is for research use only. It is not approved for use in humans or for therapeutic or diagnostic use.
Target Details


Amyloid Beta

Official Name

Full Name

Amyloid beta

Alternative Names

Beta-Amyloid Peptide; Amyloid beta peptide (beta-APP); Amyloid Beta

Gene ID

351(Human); 11820(Mouse); 54226(Rat)

Uniprot ID

P05067(Human); P12023(Mouse); P08592(Rat)

Publications (0)


Related Products
For Research Use Only. Not For Clinical Use.
Send Inquiry Send Inquiry
Inquiry Basket

Send inquiry